NASDAQ · Drug Manufacturers - Specialty & Generic

BFRI (BFRI) Stock

$1.17 -4.88% NASDAQ: BFRI Healthcare

Valuation

MetricValue
Price$1.17
Market Cap$14.98M
P/E Ratio-0.90
P/B Ratio0.97
P/S Ratio0.24
EPS (TTM)$0.00
52-Week High$1.19
52-Week Low$0.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-110.00%
ROA-37.93%
ROCE-81.82%
Gross Margin-21.43%
Operating Margin-21.43%
Net Margin-25.66%
Debt/Equity1.27
Current Ratio1.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$24.0M$29.0M$34.0M$37.0M$42.0M
Operating Profit$-25.0M$-19.0M$-23.0M$-17.0M$-9.0M
Net Profit$-38.0M$-1.0M$-20.0M$-18.0M$-11.0M
EPS$-44.10$-0.61$-13.02$-3.22$-0.90
Op Margin-104.6%-64.8%-66.6%-46.1%-21.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$53.0M$51.0M$28.0M$22.0M$29.0M
Total Liabilities$42.0M$27.0M$23.0M$18.0M$18.0M
Cash$25.0M$17.0M$1.0M$6.0M$6.0M
Borrowings$0$1.0M$5.0M$5.0M$6.0M

Latest News

Biofrontera (BFRI) Q1 2026 Earnings Transcript Motley Fool · Jun 2, 2026 Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 GlobeNewswire · May 21, 2026 StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls The Fly · May 19, 2026 Biofrontera Inc (BFRI) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... GuruFocus.com · May 14, 2026 Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates Zacks · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-27.0M$-16.0M$-25.0M$-10.0M$-13.0M
Investing Cash Flow$0$-5.0M$1.0M$0$3.0M
Financing Cash Flow$13.0M$5.0M$0$7.0M$-11.0M
Net Cash Flow$16.0M$-7.0M$-16.0M$5.0M$0
Free Cash Flow$-27.0M$-16.0M$-25.0M$-10.0M$-13.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-90.15%
Quick Ratio1.09
Interest Coverage—
Return 1Y32.93%
Return 3Y-88.23%
Return 5Y—

Ownership

Insiders Held13.18%
Institutions Held22.42%
Institutions Float Held25.82%
Institutional HolderSharesReport Date
Rosalind Advisors, Inc.1,163,9622026-03-31
AIGH Capital Management LLC915,2102026-03-31
Geode Capital Management, LLC109,3002026-03-31
Vanguard Fiduciary Trust Co61,6972026-03-31
Vanguard Capital Management LLC52,2542026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AYTU $2.28 +3.23% -1.00 $24.49M 0.00%
COCP $0.92 +0.14% -1.46 $12.68M 0.00%
DWTX $1.81 +3.14% 1.42 $3.45M 0.00%
EVGNEvogene Ltd. $0.54 -0.04% -0.41 $4.67M 0.00%
GELS $0.62 -6.94% — $5.65M 0.00%

About BFRI

BFRI is led by CEO Hermann Luebbert, employs 92 people, headquartered in US, publicly traded since 2021.

BFRI stock trades at $1.17 with a market capitalization of $14.98M. The stock is valued at a price-to-earnings (P/E) ratio of -0.90, price-to-book of 0.97, price-to-sales of 0.24. Over the past 52 weeks the stock has ranged between $0.56 and $1.19, and currently trades 1.7% below its 52-week high.

On profitability, BFRI generates a return on equity (ROE) of -110.00%, return on capital employed of -81.82%, an operating margin of -21.43%, a net profit margin of -25.66%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides